RBWA
PFE icon

RFG - Bristol Wealth Advisors’s Pfizer PFE Stock Holding History

RFG - Bristol Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Sell
19,333
-45
-0.2% -$1.18K 0.11% 115
2026
Q1 		$544K Sell
19,378
-116
-0.6% -$3.09K 0.15% 102
2025
Q4 		$485K Buy
19,494
+124
+0.6% +$3.13K 0.14% 109
2025
Q3 		$494K Buy
19,370
+5
+0% +$123 0.14% 111
2025
Q2 		$469K Sell
19,365
-1,608
-8% -$37.5K 0.15% 113
2025
Q1 		$531K Buy
20,973
+169
+0.8% +$4.42K 0.18% 99
2024
Q4 		$552K Buy
+20,804
New +$564K 0.18% 96

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RFG - Bristol Wealth Advisors's PFE Position: Q2 2026 in Review

RFG - Bristol Wealth Advisors reduced its Pfizer (PFE) stake by 0.23% in Q2 2026, selling an estimated $1.18K and leaving 19,333 shares worth $466K. The position accounts for 0.11% of the portfolio, ranked #115.

RFG - Bristol Wealth Advisors first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $552K in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • RFG - Bristol Wealth Advisors held 19,333 shares of Pfizer worth $466K as of Q2 2026.
  • RFG - Bristol Wealth Advisors sold 45 Pfizer shares in Q2 2026, an estimated $1.18K.
  • Pfizer made up 0.11% of RFG - Bristol Wealth Advisors's portfolio in Q2 2026, its #115 holding.
  • RFG - Bristol Wealth Advisors first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • RFG - Bristol Wealth Advisors's Pfizer position peaked at $552K in Q4 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.